HEADER ONCOPROTEIN 22-MAR-19 6JOJ TITLE CRYSTAL STRUCTURE OF PDGFRA T674I IN COMPLEX WITH CRENOLANIB BY TITLE 2 SOAKING COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PDGFR-ALPHA,ALPHA PLATELET-DERIVED GROWTH FACTOR RECEPTOR, COMPND 5 ALPHA-TYPE PLATELET-DERIVED GROWTH FACTOR RECEPTOR,CD140 ANTIGEN-LIKE COMPND 6 FAMILY MEMBER A,CD140A ANTIGEN,PLATELET-DERIVED GROWTH FACTOR ALPHA COMPND 7 RECEPTOR,PLATELET-DERIVED GROWTH FACTOR RECEPTOR 2,PDGFR-2; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PDGFRA, PDGFR2, RHEPDGFRA; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PDGFRA, INHIBITOR, CRENOLANIB, ONCOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR L.LIANG,X.E.YAN,C.H.YUN REVDAT 2 22-NOV-23 6JOJ 1 REMARK REVDAT 1 25-MAR-20 6JOJ 0 JRNL AUTH L.LIANG,X.E.YAN JRNL TITL CRYSTAL STRUCTURE OF PDGFRA IN COMPLEX WITH CRENOLANIB BY JRNL TITL 2 SOAKING JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (DEV_2400: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.80 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 19958 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1011 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.8067 - 4.9715 0.99 2891 139 0.2064 0.2177 REMARK 3 2 4.9715 - 3.9467 1.00 2793 141 0.1792 0.1689 REMARK 3 3 3.9467 - 3.4480 1.00 2779 141 0.2083 0.2392 REMARK 3 4 3.4480 - 3.1328 1.00 2727 152 0.2402 0.2763 REMARK 3 5 3.1328 - 2.9083 1.00 2703 171 0.2728 0.2643 REMARK 3 6 2.9083 - 2.7369 1.00 2750 135 0.2961 0.2921 REMARK 3 7 2.7369 - 2.5998 0.85 2304 132 0.3325 0.3300 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.910 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 2814 REMARK 3 ANGLE : 1.490 3815 REMARK 3 CHIRALITY : 0.094 410 REMARK 3 PLANARITY : 0.005 474 REMARK 3 DIHEDRAL : 20.617 1052 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6JOJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-MAR-19. REMARK 100 THE DEPOSITION ID IS D_1300011298. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97853 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19958 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 13.50 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5K5X REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH6.9, 1.6M (NH4)2SO4, 0.1M REMARK 280 NACL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.99567 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 73.99133 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 73.99133 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 36.99567 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 546 REMARK 465 ALA A 547 REMARK 465 MET A 548 REMARK 465 ASP A 549 REMARK 465 LYS A 550 REMARK 465 GLN A 551 REMARK 465 LYS A 552 REMARK 465 PRO A 553 REMARK 465 HIS A 768 REMARK 465 LYS A 769 REMARK 465 LYS A 770 REMARK 465 LYS A 771 REMARK 465 SER A 772 REMARK 465 MET A 773 REMARK 465 LEU A 774 REMARK 465 ASP A 775 REMARK 465 SER A 776 REMARK 465 GLU A 777 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 597 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 779 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 692 19.41 80.41 REMARK 500 ARG A 817 -0.33 79.17 REMARK 500 ASP A 818 48.22 -156.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6T2 A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1006 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1007 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1008 DBREF 6JOJ A 550 768 UNP P16234 PGFRA_HUMAN 550 696 DBREF 6JOJ A 769 973 UNP P16234 PGFRA_HUMAN 769 973 SEQADV 6JOJ GLY A 546 UNP P16234 EXPRESSION TAG SEQADV 6JOJ ALA A 547 UNP P16234 EXPRESSION TAG SEQADV 6JOJ MET A 548 UNP P16234 EXPRESSION TAG SEQADV 6JOJ ASP A 549 UNP P16234 EXPRESSION TAG SEQRES 1 A 356 GLY ALA MET ASP LYS GLN LYS PRO ARG TYR GLU ILE ARG SEQRES 2 A 356 TRP ARG VAL ILE GLU SER ILE SER PRO ASP GLY HIS GLU SEQRES 3 A 356 TYR ILE TYR VAL ASP PRO MET GLN LEU PRO TYR ASP SER SEQRES 4 A 356 ARG TRP GLU PHE PRO ARG ASP GLY LEU VAL LEU GLY ARG SEQRES 5 A 356 VAL LEU GLY SER GLY ALA PHE GLY LYS VAL VAL GLU GLY SEQRES 6 A 356 THR ALA TYR GLY LEU SER ARG SER GLN PRO VAL MET LYS SEQRES 7 A 356 VAL ALA VAL LYS MET LEU LYS PRO THR ALA ARG SER SER SEQRES 8 A 356 GLU LYS GLN ALA LEU MET SER GLU LEU LYS ILE MET THR SEQRES 9 A 356 HIS LEU GLY PRO HIS LEU ASN ILE VAL ASN LEU LEU GLY SEQRES 10 A 356 ALA CYS THR LYS SER GLY PRO ILE TYR ILE ILE THR GLU SEQRES 11 A 356 TYR CYS PHE TYR GLY ASP LEU VAL ASN TYR LEU HIS LYS SEQRES 12 A 356 ASN ARG ASP SER PHE LEU SER HIS LYS LYS LYS SER MET SEQRES 13 A 356 LEU ASP SER GLU VAL LYS ASN LEU LEU SER ASP ASP ASN SEQRES 14 A 356 SER GLU GLY LEU THR LEU LEU ASP LEU LEU SER PHE THR SEQRES 15 A 356 TYR GLN VAL ALA ARG GLY MET GLU PHE LEU ALA SER LYS SEQRES 16 A 356 ASN CYS VAL HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU SEQRES 17 A 356 LEU ALA GLN GLY LYS ILE VAL LYS ILE CYS ASP PHE GLY SEQRES 18 A 356 LEU ALA ARG ASP ILE MET HIS ASP SER ASN TYR VAL SER SEQRES 19 A 356 LYS GLY SER THR PHE LEU PRO VAL LYS TRP MET ALA PRO SEQRES 20 A 356 GLU SER ILE PHE ASP ASN LEU TYR THR THR LEU SER ASP SEQRES 21 A 356 VAL TRP SER TYR GLY ILE LEU LEU TRP GLU ILE PHE SER SEQRES 22 A 356 LEU GLY GLY THR PRO TYR PRO GLY MET MET VAL ASP SER SEQRES 23 A 356 THR PHE TYR ASN LYS ILE LYS SER GLY TYR ARG MET ALA SEQRES 24 A 356 LYS PRO ASP HIS ALA THR SER GLU VAL TYR GLU ILE MET SEQRES 25 A 356 VAL LYS CYS TRP ASN SER GLU PRO GLU LYS ARG PRO SER SEQRES 26 A 356 PHE TYR HIS LEU SER GLU ILE VAL GLU ASN LEU LEU PRO SEQRES 27 A 356 GLY GLN TYR LYS LYS SER TYR GLU LYS ILE HIS LEU ASP SEQRES 28 A 356 PHE LEU LYS SER ASP HET 6T2 A1001 33 HET SO4 A1002 5 HET SO4 A1003 5 HET CL A1004 1 HET CL A1005 1 HET CL A1006 1 HET CL A1007 1 HET CL A1008 1 HET CL A1009 1 HET CL A1010 1 HETNAM 6T2 1-(2-{5-[(3-METHYLOXETAN-3-YL)METHOXY]-1H-BENZIMIDAZOL- HETNAM 2 6T2 1-YL}QUINOLIN-8-YL)PIPERIDIN-4-AMINE HETNAM SO4 SULFATE ION HETNAM CL CHLORIDE ION HETSYN 6T2 CRENOLANIB FORMUL 2 6T2 C26 H29 N5 O2 FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 CL 7(CL 1-) FORMUL 12 HOH *35(H2 O) HELIX 1 AA1 ASP A 583 GLU A 587 5 5 HELIX 2 AA2 PRO A 589 ASP A 591 5 3 HELIX 3 AA3 ARG A 634 GLY A 652 1 19 HELIX 4 AA4 LEU A 682 ASN A 689 1 8 HELIX 5 AA5 LYS A 779 SER A 783 1 5 HELIX 6 AA6 THR A 791 LYS A 812 1 22 HELIX 7 AA7 ALA A 820 ARG A 822 5 3 HELIX 8 AA8 PRO A 858 MET A 862 5 5 HELIX 9 AA9 ALA A 863 ASN A 870 1 8 HELIX 10 AB1 THR A 873 SER A 890 1 18 HELIX 11 AB2 ASP A 902 GLY A 912 1 11 HELIX 12 AB3 THR A 922 TRP A 933 1 12 HELIX 13 AB4 GLU A 936 ARG A 940 5 5 HELIX 14 AB5 SER A 942 LEU A 953 1 12 HELIX 15 AB6 PRO A 955 SER A 972 1 18 SHEET 1 AA1 3 TYR A 572 TYR A 574 0 SHEET 2 AA1 3 ARG A 560 ILE A 565 -1 N SER A 564 O ILE A 573 SHEET 3 AA1 3 CYS A 814 VAL A 815 -1 O VAL A 815 N ARG A 560 SHEET 1 AA2 5 LEU A 593 SER A 601 0 SHEET 2 AA2 5 GLY A 605 TYR A 613 -1 O GLU A 609 N GLY A 596 SHEET 3 AA2 5 VAL A 621 LEU A 629 -1 O VAL A 624 N GLY A 610 SHEET 4 AA2 5 TYR A 671 GLU A 675 -1 O ILE A 672 N LYS A 627 SHEET 5 AA2 5 LEU A 660 CYS A 664 -1 N GLY A 662 O ILE A 673 SHEET 1 AA3 3 GLY A 680 ASP A 681 0 SHEET 2 AA3 3 VAL A 824 ALA A 827 -1 O LEU A 826 N GLY A 680 SHEET 3 AA3 3 ILE A 831 ILE A 834 -1 O LYS A 833 N LEU A 825 SHEET 1 AA4 2 VAL A 850 LYS A 852 0 SHEET 2 AA4 2 THR A 855 LEU A 857 -1 O LEU A 857 N VAL A 850 SITE 1 AC1 9 LEU A 599 ALA A 625 LYS A 627 GLU A 675 SITE 2 AC1 9 TYR A 676 CYS A 677 PHE A 678 LEU A 825 SITE 3 AC1 9 ASP A 836 SITE 1 AC2 4 ARG A 804 LYS A 959 TYR A 962 HIS A 966 SITE 1 AC3 4 HIS A 654 ARG A 804 HIS A 966 LYS A 971 SITE 1 AC4 1 SER A 942 SITE 1 AC5 1 SER A 923 SITE 1 AC6 1 ASP A 919 SITE 1 AC7 1 THR A 874 SITE 1 AC8 2 LYS A 623 LYS A 939 CRYST1 100.556 100.556 110.987 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009945 0.005742 0.000000 0.00000 SCALE2 0.000000 0.011483 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009010 0.00000